Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Elucidating the disease-modifying mechanisms of delta-9-tetrahydrocannabinol in osteoarthritis

EF 2021-22

Résumé
Knee osteoarthritis (OA) affects approximately 250 million people worldwide. It alters the whole joint structure, including the synovium that facilitates joint lubrication and the cartilage required for smooth joint mobility. Severe chronic pain and disability commonly result from joint degeneration, creating a need for effective OA therapies. Cannabis is considered a potential therapeutic for those with OA because of its analgesic and anti-inflammatory properties. However, insufficient research has been done on its disease-modifying effects, leaving physicians unable to adequately guide patients on the appropriate use of cannabis products for treating OA. Cannabis is comprised of more than 100 active cannabinoid molecules, including delta-9-tetrahydrocannabinol (THC), that can alter the activity of receptive cells in the body. Joint cartilage and synovial cells express cannabinoid receptors that allow them to interact with THC; however, its effects on the local OA joint remain unknown. I hypothesize that THC modifies OA disease progression by influencing survival, inflammation, and optimal function of joint cells and tissues. To elucidate its mechanisms of action, I will treat human OA cartilage and synovial cells with THC and identify the relevant genes and proteins that are regulated. I will also use histological techniques to identify the effects of THC on OA joint cell states (like cell death, growth/spreading, and activation), immune cell invasion, and cartilage breakdown in knee joints from mice with OA-like features given oral THC treatment. Results from this proposed study may reveal novel signaling pathways of THC in the OA joint and help to inform scientists and clinicians of the potential use of cannabinoids for treating OA.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466628
Name
Maglaviceanu Anca
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating the disease-modifying mechanisms of delta-9-tetrahydrocannabinol in osteoarthritis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Models Of Osteoarthritis; Cell Signaling; Chondrocytes; Delta-9-Tetrahydrocannabinol; Disease Modification; Fibroblast-Like Synoviocytes; Histopathology; Immunomodulation; Therapy; Transcriptomics
Abstract
Knee osteoarthritis (OA) affects approximately 250 million people worldwide. It alters the whole joint structure, including the synovium that facilitates joint lubrication and the cartilage required for smooth joint mobility. Severe chronic pain and disability commonly result from joint degeneration, creating a need for effective OA therapies. Cannabis is considered a potential therapeutic for those with OA because of its analgesic and anti-inflammatory properties. However, insufficient research has been done on its disease-modifying effects, leaving physicians unable to adequately guide patients on the appropriate use of cannabis products for treating OA. Cannabis is comprised of more than 100 active cannabinoid molecules, including delta-9-tetrahydrocannabinol (THC), that can alter the activity of receptive cells in the body. Joint cartilage and synovial cells express cannabinoid receptors that allow them to interact with THC; however, its effects on the local OA joint remain unknown. I hypothesize that THC modifies OA disease progression by influencing survival, inflammation, and optimal function of joint cells and tissues. To elucidate its mechanisms of action, I will treat human OA cartilage and synovial cells with THC and identify the relevant genes and proteins that are regulated. I will also use histological techniques to identify the effects of THC on OA joint cell states (like cell death, growth/spreading, and activation), immune cell invasion, and cartilage breakdown in knee joints from mice with OA-like features given oral THC treatment. Results from this proposed study may reveal novel signaling pathways of THC in the OA joint and help to inform scientists and clinicians of the potential use of cannabinoids for treating OA.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Maglaviceanu, Anca
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~